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Abstract Triply-fused 1,3-diazepine derivatives have been obtained by acidic reduction of 
rotationally locked and sterically hindered nitro groups in the presence of an aldehyde or 
ketone. The nitro groups are sited on adjacent rings of a dicyanodibenzothiophene-5,5-
dioxide which also displays fully reversible two-electron accepting behavior. The synthesis, 
crystallographically determined molecular structures and aspects of the electronic properties 
of these new molecules are presented.  
Developing new routes to underexplored heterocyclic motifs is a fundamental driving force in 
organic chemistry and is essential to identifying new structures of medicinal or technological 
value. Diazepines are of major pharmaceutical importance.1–3 1,2- and 1,4-benzodiazepines in 
particular comprise entire classes of drugs, including the anti-anxiety medications tofisopam 
(strictly a 2,3-diazepine) and diazepam.4–8 1,3-Diazepines, and the saturated analogues 1,3-
diazepanes, are less prevalent; however they have been studied as HIV protease inhibitors,9–14 
as anti-cancer15–20 and anti-viral agents,15,21–28 and also as N-heterocyclic carbene ligands.29,30 
In comparison with 1,2- and 1,4-diazepines, routes to 1,3-diazepines are less clearly 
established. Since the last comprehensive survey of their synthesis31 only a handful of new 
synthetic approaches have been reported for monocyclic,32–35 singly-36–39 or doubly-ring-
fused 1,3-diazepines.40–49  
In this work the introduction of sterically hindered nitro groups at the 1- and 9-positions of a 
dibenzothiophene-5,5-dioxide derivative provides access to a new two-electron accepting 
molecule, which is a precursor to luminescent four-ring-fused 2,3-dihydro-1,3-diazepines 6-8 
using facile protocols in synthetically viable yields. To our knowledge these molecules 
represent the first examples of tetracyclic 1,3-diazepine derivatives. 
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Scheme 1. Synthesis of the new acceptor 5 and its X-ray molecular structure. 
The synthesis of the new dibenzothiophene-5,5-dioxide acceptor is shown in Scheme 1. 
Simultaneous cyclization and acidic hydrolysis of dimethyl biphenyl-4,4’-dicarboxylate 1 
was achieved in refluxing chlorosulfonic acid according to the procedure of Olkhovik et al to 
produce the diacid 2.50 In the same report, mononitration of 2 at the 1-position was 
performed, therefore, by using the more concentrated fuming nitric acid and extending the 
reaction time dinitration was achieved to produce 1,9-dinitrodibenzothiophene-5,5-dioxide-
3,7-dicarboxylic acid 3. A byproduct containing a nitro group in the 2-position was reported 
for the mononitration;50 however, we did not observe this during our dinitration process. 
Finally, the carboxylic acid groups of 3 were easily converted to nitriles using standard 
procedures. Reaction of 3 with an excess of refluxing SOCl2 and a catalytic amount of N,N-
dimethylformamide (DMF) gave the presumed diacyl chloride derivative, which was reacted 
immediately with aqueous ammonia to produce the diamide derivative 4, which had low 
solubility. Compound 4 was then dehydrated with POCl3 to give 5. Each step in Scheme 1 is 
straightforward to perform relying upon simple precipitation and filtration to isolate products. 
The overall yield is 54% for the five-step sequence to compound 5.  
Considerable twisting of the aromatic skeleton of 5 occurs due to a combination of steric 
hindrance and repulsive electronic effects between the nitro groups. Relief of this ring-strain 
should be a useful driving force in exploiting the reactivity of these nitro groups towards 
producing new heterocycles. Indeed, reduction of the nitro groups of 5 in the presence of 
aldehydes or ketones provides convenient access to the brightly colored 2,3-dihydro-1,3-
diazepines 6‒8 featuring alkyl or aromatic substituents at the 2-position, via the diamine 9 
(Scheme 2). 
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Scheme 2. Synthesis of tetracyclic 1,3-diazepines 6, 7 and 8 from 5 via intermediate diamine 
9, and the X-ray molecular structure of 6.   
Acidic reduction of 5 using SnCl2.2H2O in the presence of acetone provided the N,N’-
isopropylidene-2,3-dihydro-1,3-diazepine derivative 6. The modest yield (45%) is offset by 
the straightforward practical protocol. To confirm the intermediacy of the diamine 9 in this 
process a separate experiment was performed in which 9 was isolated, albeit in only 14% 
yield, and then cyclized in acidic acetone to provide 6 in 78% yield. The one-pot approach is, 
therefore, much more expedient than performing the reduction and cyclization sequentially, 
due to difficulties in isolating the diamine 9. Analogous one-pot reactions using 
cyclohexanone and 4-tert-butylbenzaldehyde gave 7 and 8, respectively, in 44% and 39% 
yields. 
We note that electrochemical reduction of 2,2’-dinitrobiphenyl in the presence of 
aldehydes and ketones has previously been used to produce 1,3-diazepines.51 However, the 
reaction conditions reported above for converting 9 into 6 did not work with 2,2’-
dinitrobiphenyl; no diazepine was isolated and the only major product identified was 2,2’-
diaminobiphenyl. This agrees with a previously reported high yielding, tin-mediated, 
reduction of this52 and related compounds.53,54 We are aware of one example of a reductive 
cyclization of a 2,2’-dinitrobiaryl using SnCl2 and an identical reaction stoichiometry to the 
present work which resulted in trace (5%) benzo[c]cinnoline formation.55 These results 
indicate that the structurally enforced proximity of the two amino groups in 9 is required for 
efficient reductive cyclization.  
 
Figure 1. Absorption (solid line) and emission spectra (dashed line) for compounds 5‒8 in 
MeCN solution. 
The diazepines 6‒8 were brightly colored and emissive in both the solid state and in 
solution, unlike the precursor 5 which is non-emissive. Absorption and emission spectra in 
acetonitrile are shown in Figure 1 and summarized in Table S1. The absorption and emission 
in the visible region for 6‒8 is probably due to strong intramolecular charge transfer between 
the electron rich diazepine and electron poor dibenzothiophene-5,5-dioxide regions. This 
postulation is strengthened by solvatochromism observed as a blue shift in emission of up to 
26 nm when moving from highly polar acetonitrile (εr = 37.5) to less polar chloroform (εr = 
4.81, Figure S1 and Table S1). There is a substantial difference in color between the ketone 
products 6 and 7 (orange) and aldehyde product 8 (yellow).  
The molecular structures of 5 (in three different crystal forms) and 6 were determined 
by single-crystal X-ray diffraction (see SI) and, in good agreement, calculated using density 
functional theory (DFT, B3LYP/6-31G*).  Both methods show molecule 5 adopting a twisted 
conformation of the dibenzothiophene system, in order to widen the short contacts N…N and 
N…O between adjacent nitro-groups (Table 1), whereas in 6 the dibenzothiophene unit is 
practically planar, N(2) and N(3) are coplanar with it and their (post-cyclization) separation is 
much shorter than in 5, the C6-C7 bond also shortening slightly. The 1,3-diazepine ring of 6 
adopts a half-chair conformation with the N2-C15-N3 fragment inclined to the 
dibenzothiophene plane by 51.5(1)° (cf. calculated 34.6°). The accurate prediction of 
structures 5 and 6 by DFT analysis encouraged us to perform it for 9 whose single crystals 
could not be obtained. The predicted structure is intermediate between those of 5 and 6 
(Figure S5, Table 1). 
Table 1. Experimental and calculated torsion angles (°) and interatomic distances (Å)a 
Molecule 5 6 9 
C5-C6-C7-C8 / DFT 18.2 0 16.3 
X-ray 18.0-23.5 1.2 - 
C1-C6-C7-C12 / DFT 13.1 0 8.7 
X-ray 12.0-14.4 0.7 - 
N2…N3 / DFT 2.997 2.411 2.774 
X-ray 2.901(3)-3.001(2) 2.425(2) - 
N2…O5 / DFT 2.681 -  
X-ray 2.587(7)-2.717(2) - - 
C6-C7 / DFT 1.490 1.474  
X-ray 1.486(2)-1.494(4) 1.472(2) - 
a For atom numbering see Schemes 1 and 2.  
 
Figure 2. HOMO (lower) and LUMO (upper) contours for 5 and 6 and their calculated 
energies. 
Molecular orbital distributions for 5 and 6 (Figure 2) show a major contribution to the 
LUMO of 5 from the nitro groups, the nitrogen atoms of which subsequently become HOMO 
contributors upon reduction and cyclization to 6. The results of identical calculations for 9 are 
shown in Figure S6. 
Electrochemistry 
 Figure 3. Cyclic voltammetry of 5  
An interesting feature of the diazepine precursor compound 5 is its ability to accept 
two electrons as shown in cyclic voltammetry (CV) experiments. The voltammogram in 
Figure 3 shows two, sequential, single-electron reductions at half wave potentials of ‒0.15 
and ‒0.45 V. Both processes are cleanly reversible displaying a linear dependence between 
peak current and the square root of the scan rate (Figures S8 and S9) and peak separations 
close to the 59 mV expected for a 1-electron wave. The data are summarized in Table S4 
alongside a more detailed discussion of the properties of 5 in comparison with some related 
fluorenone based acceptors.56  
In conclusion, an efficient synthetic route has been established to an unusual highly-
functionalized fused-ring 2,3-dihydro-1,3-diazepine system from the key dinitro compound 5 
based on a one-pot reduction followed by reaction with aldehyde or ketone functionality. A 
comparison with 2,2’-dinitrobiphenyl shows that the structurally-enforced proximity of the 
two amino groups in 9 is required for diazepine formation. There is scope to exploit this 
chemistry in the synthesis of other interesting products. For example, the close proximity of 
the nitro groups in 5 suggests that ring closure to benzo[c]cinnoline type scaffolds may also 
be feasible using alternative reaction conditions,57–59 while other suitably nitrated carbo- and 
heterocycles such as fluorenes or carbazoles might behave similarly to 5, providing further 
structural diversity for fused-ring 1,3-diazepines. 
EXPERIMENTAL 
General methods. All reactions requiring an inert atmosphere were performed under a 
blanket or argon or nitrogen gas which was dried though a column of phosphorus pentoxide. 
Anhydrous solvents were dried through an HPLC column on an innovative Technology Inc. 
solvent purification system. All reactants and reagents were purchased from commercial 
suppliers and used without further purification unless otherwise stated. Column 
chromatography was carried out using silica gel 60: 40-60 µm mesh (Fluorochem). 
Analytical thin-layer chromatography was performed on precoated aluminium silica gel 60 
F254 plates (Merck) which were approximately 2x6 cm in size and visualization was made 
using ultraviolet light (254/365 nm). NMR spectra were recorded on: Bruker Avance-400 (1H 
NMR (400 MHz), 13C (101 MHz) Varian Inova-500 (13C NMR (125MHz) and Varian 
VNMRS-700 (1H (700 MHz), 13C (175 MHz)) NMR spectrometers. Chemical shifts are 
reported in ppm downfield of tetramethylsilane (TMS) using TMS or the residual solvent as 
an internal reference. NMR spectra were processed using MestreNova. Multiplicities are 
reported as singlet (s), doublet (d), triplet (t), and multiplet (m). Melting points were 
determined in open-ended capillaries using Stuart Scientific SMP3 melting point apparatus at 
a ramping rate of 1 °C/min. They are recorded to the nearest 1 °C and are uncorrected. Mass 
spectrometry data were generated by Waters Ltd, UK (atmospheric solids analysis probe 
(ASAP) mass spectrometry). IR spectra were collected on a Perkin-Elmer Spectrum Two IR 
spectrometer. Elemental analyses were obtained on an Exeter Analytical Inc. CE-440 
elemental analyzer. Cyclic voltammetry was recorded using a Princeton Applied Research 
VersaSTAT 3. Glassy carbon disk, Pt wire and Ag/Ag+ (AgNO3 in acetonitrile) were used as 
the working, counter and reference electrodes respectively. Measurements were corrected to 
the ferrocene/ferrocenium redox couple as an internal standard and represented versus 
Ag/AgCl which occurred at ‒0.45 V versus Fc/Fc+ in these conditions. Acetonitrile was used 
as the solvent with an analyte molarity of ca. 10-4 M in the presence of 1 × 10-3 M (n-
Bu4N)(PF6) as supporting electrolyte. Solutions were degassed with Ar and experiments run 
under a blanket of Ar. UV/Vis absorbance spectra were measured using a UV-1800 UV-Vis 
Spectrophotometer (Shimadzu) and UVProbe version 2.33 software. Emission spectra were 
recorded on an SPEX Fluoromax luminescence spectrometer using dM300 version 3.12 
software. Density function theory (DFT) calculations were performed with ORCA v4.0160 
using the B3LYP hybrid functional and 6-31G* basis set.61–63 Ground state structural 
optimizations were performed prior to frontier orbital calculations. 
5,5-Dioxo-5H-dibenzo[b,d]thiophene-3,7-dicarboxylic acid (2):50 A solution of dimethyl 
biphenyl-4,4’-dicarboxylate 1 (5.00 g, 19.0 mmol) in chlorosulfonic acid (20 mL) was heated 
at reflux for 3 h. The reaction mixture was cooled to room temperature and poured over ice to 
precipitate the product. The white precipitate was filtered and washed with water (50 mL), 
hexane (40 mL) and diethyl ether (40 mL). The white powder was recrystallized from 
acetone to afford 2 as a white crystalline solid (5.51 g, 95%). Mp: > 350 °C; 1H NMR (400 
MHz, DMSO-d6, ppm) δ = 8.43 (2H, d, J = 7.7 Hz, H1/9), 8.38 (2H, d, J = 0.9 Hz, H4/6), 8.36 
(2H, dd, J = 8.0, 1.5 Hz, H2/8). 
1,9-Dinitro-5,5-dioxo-5H-dibenzo[b,d]thiophene-3,7-dicarboxylic acid (3): A 1 L two-
necked round bottom flask equipped with a water cooled reflux condenser and a pressure 
equalizing dropping funnel was charged with 2 (18.0 g, 59.2 mmol) and 95% sulfuric acid (d 
= 1.83, 165 mL) and placed in an ice batch. Fuming 90% nitric acid (d = 1.50, 250 mL) was 
added cautiously using to the stirred solution through the dropping funnel while maintaining 
the temperature between 5‒10 °C. The ice bath was swapped for a heating block which was 
then slowly heated to 130 °C for 48 h. To minimize corrosive vapors escaping the reaction 
vessel the top of the reflux condenser was connected by PVC tubing to an empty 500 mL 
Dreschel bottle (to avoid the risk of suck back into the reaction vessel) which in turn was 
connected by another length of PVC tubing the end of which was submerged approximately 2 
cm below the surface of 400 mL of water in a 1 L beaker. After heating, the mixture was 
allowed to cool then poured over ice. The white precipitate that formed was filtered and 
washed with water (60 mL) then hexane (40 mL). The crude product was recrystallized from 
acetic acid to afford 3 as a white crystalline solid (17.1 g, 73%). Mp: >350 °C; 1H NMR (400 
MHz, DMSO-d6, ppm) δ = 8.89 (2H, d, J = 1.5 Hz, H2/8), 8.71 (2H, d, J = 1.5 Hz, H4/6); 13C 
NMR (101 MHz, DMSO-d6, ppm) δ = 163.6, 146.3, 141.0, 137.0, 131.1, 127.1, 123.9; IR 
(νmax/cm-1 ) 3095 (w), 2523 (br), 1707 (s, C=O), 1543 and 1359 (s, NO2), 1326 and 1146 (s, 
SO2), 1279 (s), 1185 (s), 1172 (s), 744 (s); MS (ASAP) m/z: 395.0 [M + H]+; HRMS (ASAP) 
m/z: [M + H]+ Calcd for C14H7N2O10S 394.9816; Found 394.9811. 
1,9-Dinitro-5,5-dioxo-5H-dibenzo[b,d]thiophene-3,7-dicarboxamide (4): A few drops of 
DMF were added to a suspension of 3 (15.0 g, 38.0 mmol) in thionyl chloride (380 mL) 
which was then heated to reflux for 3 h to form a yellow solution. Upon cooling to room 
temperature the excess thionyl chloride was removed under reduced pressure to afford a pale 
yellow solid (16.4 g, 38.0 mmol). The yellow solid was then suspended in water (20 mL) 
with stirring before 35% aqueous ammonia solution (d = 0.88, 200 mL) was very carefully 
added dropwise (CAUTION! gas evolution). The reaction mixture was left to stir at room 
temperature for 2.5 h then poured over ice to produce a brown precipitate which was filtered 
off and washed with diethyl ether (50 mL) then hexane (50 mL) to yield 4 as a pale brown 
solid (12.7 g, 86%). The compound was used without further purification. Mp: 230 °C (dec.); 
1H NMR (400 MHz, DMSO-d6, ppm) δ = 8.96 (2H, d, J = 1.0 Hz, H2/8), 8.81 (2H, d, J = 1.0 
Hz, H4/6), 8.61 (2H, s, ‒NH), 8.12 (2H, s, ‒NH); 13C NMR (101 MHz, DMSO-d6, ppm) δ = 
163.3, 146.2, 140.7, 139.6 , 129.9, 125.4, 122.9; IR (νmax/cm-1 ) 3083 (br), 2924 (w), 1693 (s, 
C=O),  1616 (m, amide‒H) 1541 and 1352 (s, NO2), 1314 and 1145 (s, SO2), 1386 (m), 1192 
(m); MS (ASAP) m/z: 393.0 [M + H]+;  HRMS (ASAP) m/z: [M + H]+ Calcd for 
C14H9N4O8S 393.0136; Found 393.0135. 
3,7-Dicyano-1,9-dinitro-5,5-dioxo-5H-dibenzo[b,d]thiophene (5): A solution of 4 (1.60 g, 
4.08 mmol) in phosphorus oxychloride (40 mL) was heated to reflux for 3 h. The resulting 
dark orange solution was cooled to room temperature and quenched slowly with warm water. 
The orange precipitate was filtered and washed with water (50 mL) and hexane (30 mL). The 
crude product was recrystallized from acetonitrile and water to afford 5 as pale yellow 
crystals (1.30 g, 90%). Mp: 250 °C (dec.); Elemental Anal. Calcd for C14H4N4O6S: C 47.20, 
H 1.13 N 15.73, Found: C 46.84, H 1.12, N 15.70; 1H NMR (400 MHz, acetone-d6, ppm) δ = 
9.08 (2H, d, J = 1.5 Hz, H2/8), 9.02 (2H, d, J = 1.5 Hz, H4/6); 13C NMR (101 MHz, acetone-d6, 
ppm) δ = 147.9, 142.8, 135.4, 131.6, 125.5, 119.0, 115.8; IR (νmax/cm-1 ) 3074 (w), 2242 
(C≡N, w), 1547 and 1352 (NO2, s), 1495 (m), 1330 and 1161 (SO2, s), 1227 (m), 1188 (m), 
778 (m), 737 (s), 694 (s), 575 (m), 544 (s), 467 (s). Despite repeated attempts using a range of 
techniques, this molecule was not observed by mass spectrometry. Single crystals for X-ray 
analysis were grown from both ethyl acetate/hexane and THF/MeOH/H2O solutions. 
N,N'-isopropylidene-1,9-diamino-3,7-dicyano-5,5-dioxo-5H-dibenzo[b,d]thiophene (6): 
To a stirred solution of SnCl2.2H2O (3.00 g, 13.4 mmol) in a mixture of methanol (8.50 mL) 
and aqueous HCl (2 M, 8.5 mL), acetone (1.00 mL, 13.6 mmol, 16 eq.) and 5 (0.30 g, 0.84 
mmol) were added sequentially. The mixture was then heated to 85 °C for 2.5 h. The mixture 
was cooled to room temperature and poured into aqueous HCl (2 M, 34 mL). An orange 
precipitate immediately formed which was filtered and washed with hexane (30 mL). It was 
then purified by silica column chromatography (eluent: 30:70 hexane: ethyl acetate (v/v)) to 
afford 6 as an orange powder (128 mg, 45%). Mp: 350 °C (dec.); 1H NMR (400 MHz, 
acetone-d6, ppm) δ = 7.64 (2H, d, J = 1.3 Hz, H4/6), 7.44 (2H, d, J = 1.3 Hz, H2/8), 6.98 (2H, s, 
‒NH‒), 1.63 (6H, s, ‒CH3); 13C NMR (101 MHz, acetone-d6, ppm) δ = 146.1, 140.2, 126.9, 
119.1, 118.0, 114.6, 114.3, 67.2, 28.4; IR (νmax/cm-1 ) 3331 (N‒H, m), 2917 (w), 2233 (C≡N, 
m), 1740 (m), 1606 (m), 1526 (m), 1457 (m), 1367 (m), 1308 and 1150 (SO2, s), 1278 (m), 
1028 (m), 876 (m), 713 (m), 624 (m), 545(s); MS (ASAP) m/z: 337.1 [M + H]+; HRMS 
(ASAP) m/z: [M + H]+ Calcd. for C17H13N4O2S 337.0754; Found 337.0753. 
N,N'-cyclohexylidene-1,9-diamino-3,7-dicyano-5,5-dioxo-5H-dibenzo[b,d]thiophene (7): 
To a stirred solution of SnCl2.2H2O (5.07 g, 22.5 mmol) in a mixture of methanol (14 mL) 
and aqueous HCl (2 M, 14 mL), cyclohexanone (0.73 mL, 7.0 mmol) and 5 (0.50 g, 1.40 
mmol) were added. The mixture was then heated to 85 °C for 2.5 h. The mixture was cooled 
to room temperature and poured into aqueous HCl (2 M, 56 mL). An orange precipitate 
immediately formed which was filtered and washed with hexane (30 mL). It was then 
purified by silica column chromatography (eluent: 40:60 hexane: ethyl acetate (v/v)) to afford 
7 as small orange crystals (230 mg, 44%). Mp: 300 °C (dec.); 1H NMR (400 MHz, acetone-
d6, ppm) δ = 7.64 (2H, d, J = 1.3 Hz, H4/6), 7.59 (2H, d, J = 1.3 Hz, H2/8), 6.84 (2H s, ‒NH‒), 
1.92 – 1.84 (4H, m, ‒CH2‒), 1.69 – 1.49 (6H, m, ‒CH2‒); 13C NMR (101 MHz, acetone-d6, 
ppm) δ = 145.5, 140.1, 127.2, 119.6, 118.0, 114.7, 114.3, 68.8, 36.1, 25.8, 22.4; IR (νmax/cm-1 
) 3401 (m), 3356 (m), 3321 (N‒H, m), 3076 (w), 2941 (w), 2241 (C≡N, m), 1606 (m), 1517 
(s), 1305 and 1150 (SO2, s) 852 (m), 708 (m), 620 (m); MS (ASAP) m/z: 377.1 [M + H]+; 
HRMS (ASAP) m/z: [M + H]+ Calcd. for C20H17N4O2S 377.1067; Found: 377.1067. 
N,N'-(4-tert-butylbenzylidene)-1,9-diamino-3,7-dicyano-5,5-dioxo-5H-
dibenzo[b,d]thiophene (8): To a stirred solution of SnCl2.2H2O (2.02 g, 8.99 mmol) in a 
mixture of methanol (6 mL) and aqueous HCl (2 M, 6 mL), 4-tert-butylbenzaldehyde (0.50 
mL, 2.81 mmol) and 5 (0.20 g, 0.56 mmol) were added. The mixture was then heated to 85 
°C for 2.5 h. The mixture was cooled to room temperature and poured into aqueous HCl (2 
M, 25 mL). The organics were then extracted into ethyl acetate (3 x 15 mL) and washed with 
water (2 x 25 mL). The organic fractions were dried over magnesium sulfate and the ethyl 
acetate removed under vacuum to afford an oil. The oil was dissolved in dichloromethane (30 
mL) and hexane (20 mL) was added. The solvent was reduced in volume (ca. 10 mL) to 
precipitate the crude product as a yellow powder. It was then purified by silica column 
chromatography (eluent: 70:30 hexane: ethyl acetate (v/v)) to afford 8 as a yellow crystalline 
powder (92 mg, 39%). Mp: 300 °C (dec.); 1H NMR (400 MHz, acetone-d6, ppm) δ = 7.69 
(2H, d, J = 1.4 Hz, H4/6), 7.65 (2H, d, J = 1.4 Hz, H2/8), 7.58 – 7.48 (4H, m, H4-t-BuC6H4), 7.17 
(2H, s, ‒NH‒), 5.34 (1H, s, ‒CH‒), 1.36 (9H, s, ‒CH3); 13C NMR (101 MHz, acetone-d6, 
ppm) δ = 153.2, 148.5, 140.7, 136.7, 128.3, 126.9, 126.4, 118.9, 118.0, 115.2, 113.8, 71.2, 
35.3, 31.6; IR (νmax/cm-1 ) 3355 (N‒H, w), 3063 (w), 2956 (w), 2233 (C≡N, m), 1605 (m), 
1505 (s), 1468 (s), 1305 and 1145 (SO2, s), 1268 (m), 1202 (m), 886 (m), 836 (m), 707 (m), 
621 (m); MS (ASAP) m/z: 441.1 [M + H]+; HRMS (ASAP) m/z: [M + H]+ Calcd. for 
C25H21N4O2S 441.1380; Found: 441.1374. 
1,9-diamino-3,7-dicyano-5,5-dioxo-5H-dibenzo[b,d]thiophene (9): To a stirred solution of 
SnCl2.2H2O (5.07 g, 22.5 mmol) in a mixture of ethanol (14 mL) and aqueous HCl (2 M, 14 
mL), 5 (0.50 g, 1.40 mmol) was added. The mixture was heated to 85 °C for 2.5 h then 
cooled to room temperature and poured into aqueous HCl (2 M, 56 mL). An orange 
precipitate immediately formed which was filtered and washed with hexane (30 mL). The 
product was purified by silica column chromatography (eluent: started 30:70 hexane: ethyl 
acetate (v/v) gradually increased polarity to 100% ethyl acetate) to afford 9 as a light brown 
powder (60 mg, 14%). Mp: 300 °C (dec.); 1H NMR (400 MHz, DMSO-D6, ppm) δ = 7.79 
(2H, d, J = 1.5 Hz, H4/6), 7.52 (2H, d, J = 1.5 Hz, H2/8), 6.60 (4H, s, ‒NH2); 13C NMR (101 
MHz, DMSO- D6, ppm) δ = 145.0, 139.1, 126.5, 118.1, 117.6, 112.9, 112.6; IR (νmax/cm-1 ) 
3451 and 3360 (N-H, m), 3243 (w), 3070 (w), 2226 (C≡N, s), 1632 and 1598 (NH2, s), 1543 
(m), 1467 (m), 1430 (m),  1346 (m), 1299 and 1143 (SO2, s), 1253 (m), 1194 (m), 881 (m), 
617 (m).  MS (ASAP) m/z: 297.0 [M + H]+; HRMS (ASAP) m/z: [M + H]+ Calcd. for 
C14H9N4O2S 297.0441; Found: 297.0437. 
 
ASSOCIATED CONTENT 
Supporting Information 
1H and 13C NMR spectra for all new compounds, absorption and emission spectra, 
computational details for 5, 6, and 9 and computational results for 9, electrochemical 
properties of 1 and further crystallographic details (PDF). 
CIF files for 5, 5·½THF and 6. 
Crystallographic data uploaded to Cambridge Crystallographic Database: CCDC 1850071-
1850073. 
 
AUTHOR INFORMATION 
Corresponding Authors 
*E-mails and ORCID: m.r.bryce@durham.ac.uk; ORCID 0000-0003-2097-7823 (M.R.B.). 
i.a.wright@lboro.ac.uk; ORCID 0000-0002-0142-2809 (I.A.W.). 
Notes 
The authors declare no competing financial interest. 
ACKNOWLEDGEMENTS 
M.R.B. and I.A.W. thank EPRSC for funding (Grant No. EP/K016164/1). I.A.W. thanks 
Loughborough University and the Royal Society of Chemistry Research Fund (Grant No. RF18-5353) 
for funding. 
 
References 
(1)  Schütz, H. Benzodiazepines; Springer Berlin Heidelberg: Berlin, Heidelberg, 1982. 
(2)  Schuetz, H. Benzodiazepines II. A Handbook.; Springer Berlin Heidelberg: Berlin, 
Heidelberg, 1989. 
(3)  Hosmane, R. S. Ring-Expanded (’fat’) Purines and Their Nucleoside/nucleotide 
Analogues as Broad-Spectrum Therapeutics. In Progress in Heterocyclic Chemistry; 
2009; Vol. 21, pp 35–68. 
(4)  Smith, S. G.; Sanchez, R.; Zhou, M. M. Privileged Diazepine Compounds and Their 
Emergence as Bromodomain Inhibitors. Chem. Biol. 2014, 21 (5), 573–583. 
(5)  Meagher, T. P.; Murugan, R. 1,2-Diazepines. In Comprehensive Heterocyclic 
Chemistry III; Elsevier, 2008; pp 143–160. 
(6)  Snieckus, V.; Streith, J. 1,2-Diazepines: A New Vista in Heterocyclic Chemistry. Acc. 
Chem. Res. 1981, 14 (11), 348–355. 
(7)  Kaur, N.; Kishore, D. Synthetic Strategies Applicable in the Synthesis of Privileged 
Scaffold: 1,4-Benzodiazepine. Synth. Commun. 2014, 44 (10), 1375–1413. 
(8)  Meanwell, N. A.; Walker, M. A. 1,4-Diazepines. In Comprehensive Heterocyclic 
Chemistry III; Elsevier, 2008; pp 183–235. 
(9)  Hodge, C. N.; Lam, P. Y. S.; Eyermann, C. J.; Jadhav, P. K.; Ru, Y.; Fernandez, C. H.; 
De Lucca, G. V.; Chang, C. H.; Kaltenbach, R. F.; Holler, E. R.; et al. Calculated and 
Experimental Low-Energy Conformations of Cyclic Urea HIV Protease Inhibitors. J. 
Am. Chem. Soc. 1998, 120 (19), 4570–4581. 
(10)  Jadhav, P. K.; Ala, P.; Woerner, F. J.; Chang, C. H.; Garber, S. S.; Anton, E. D.; 
Bacheler, L. T. Cyclic Urea Amides: Hiv-1 Protease Inhibitors with Low Nanomolar 
Potency against Both Wild Type and Protease Inhibitor Resistant Mutants of HIV. J. 
Med. Chem. 1997, 40 (2), 181–191. 
(11)  Han, W.; Pelletier, J. C.; Hodge, C. N. Tricylic Ureas: A New Class of HIV-1 Protease 
Inhibitors. Bioorganic Med. Chem. Lett. 1998, 8 (24), 3615–3620. 
(12)  Debnath, A. K. Three-Dimensional Quantitative Structure-Activity Relationship Study 
on Cyclic Urea Derivatives as HIV-1 Protease Inhibitors: Application of Comparative 
Molecular Field Analysis. J. Med. Chem. 1999, 42 (2), 249–259. 
(13)  Lam, P. Y. S.; Ru, Y.; Jadhav, P. K.; Aldrich, P. E.; DeLucca, G. V.; Eyermann, C. J.; 
Chang, C.-H.; Emmett, G.; Holler, E. R.; Daneker, W. F.; et al. Cyclic HIV Protease 
Inhibitors:  Synthesis, Conformational Analysis, P2/P2‘ Structure−Activity 
Relationship, and Molecular Recognition of Cyclic Ureas. J. Med. Chem. 1996, 39 
(18), 3514–3525. 
(14)  Lam, P. Y. S.; Jadhav, P. K.; Eyermann, C. J.; Hodge, C. N.; Ru, Y.; Bacheler, L. T.; 
Meek, J. L.; Otto, M. J.; Rayner, M. M.; Wong, Y. N.; et al. Rational Design of Potent, 
Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease Inhibitors. Science 1994, 263, 
380–384. 
(15)  Wittine, K.; Poljak, K.; Kovac, M.; Makuc, D.; Plavec, J.; Balzarini, J.; Martinovic, T.; 
Pavelic, S. K.; Pavelic, K.; Mintas, M. The Novel [4,5-e][1,3]Diazepine-4,8-Dione and 
Acyclic Carbamoyl Imino-Ureido Derivatives of Imidazole: Synthesis, Anti-Viral and 
Anti-Tumor Activity Evaluations. Molecules 2013, 18 (11), 13385–13397. 
(16)  Xie, M.; Lapidus, R. G.; Sadowska, M.; Edelman, M. J.; Hosmane, R. S. Synthesis, 
Anticancer Activity, and SAR Analyses of Compounds Containing the 5:7-Fused 
4,6,8-triaminoimidazo[4,5-e][1,3]diazepine Ring System. Bioorganic Med. Chem. 
2016, 24 (12), 2595–2602. 
(17)  Kondaskar, A.; Kondaskar, S.; Kumar, R.; Fishbein, J. C.; Muvarak, N.; Lapidus, R. 
G.; Sadowska, M.; Edelman, M. J.; Bol, G. M.; Vesuna, F.; et al. Novel, Broad 
Spectrum Anticancer Agents Containing the Tricyclic 5:7:5-Fused Diimidazodiazepine 
Ring System. ACS Med. Chem. Lett. 2011, 2 (3), 252–256. 
(18)  Kondaskar, A.; Kondaskar, S.; Fishbein, J. C.; Carter-Cooper, B. A.; Lapidus, R. G.; 
Sadowska, M.; Edelman, M. J.; Hosmane, R. S. Structure-Based Drug Design and 
Potent Anti-Cancer Activity of Tricyclic 5:7:5-Fused diimidazo[4,5-d:4′,5′-
f][1,3]diazepines. Bioorganic Med. Chem. 2013, 21 (3), 618–631. 
(19)  Bellet, V.; Lichon, L.; Arama, D. P.; Gallud, A.; Lisowski, V.; Maillard, L. T.; Garcia, 
M.; Martinez, J.; Masurier, N. Imidazopyridine-Fused [1,3]-Diazepinones Part 2: 
Structure-Activity Relationships and Antiproliferative Activity against Melanoma 
Cells. Eur. J. Med. Chem. 2017, 125, 1225–1234. 
(20)  Gallud, A.; Vaillant, O.; Maillard, L. T.; Arama, D. P.; Dubois, J.; Maynadier, M.; 
Lisowski, V.; Garcia, M.; Martinez, J.; Masurier, N. Imidazopyridine-Fused [1,3]-
Diazepinones: Synthesis and Antiproliferative Activity. Eur. J. Med. Chem. 2014, 75, 
382–390. 
(21)  Zhang, N.; Chen, H. M.; Sood, R.; Kalicharran, K.; Fattom, A. I.; Naso, R. B.; 
Barnard, D. L.; Sidwell, R. W.; Hosmane, R. S. In Vitro Inhibition of the Measles 
Virus by Novel Ring-Expanded (’fat’) Nucleoside Analogues Containing the 
imidazo[4,5-e][1,3]diazepine Ring System. Bioorganic Med. Chem. Lett. 2002, 12 
(23), 3391–3394. 
(22)  Zhang, P.; Zhang, N.; Buckwold, V. E.; Hosmane, R. S. Chemical and Biological 
Effects of Substitution of the 2-Position of Ring-Expanded (’fat’) Nucleosides 
Containing the imidazo[4,5-e][1,3]diazepine-4,8-Dione Ring System: The Role of 
Electronic and Steric Factors on Glycosidic Bond Stability and Anti-HCV a. 
Bioorganic Med. Chem. 2007, 15 (14), 4933–4945. 
(23)  Zhang, P.; Zhang, N.; Korba, B. E.; Hosmane, R. S. Structure-Activity Relationship 
Studies on Anti-HCV Activity of Ring-Expanded (’fat’) Nucleobase Analogues 
Containing the imidazo[4,5-e][1,3]diazepine-4,8-Dione Ring System. Bioorganic Med. 
Chem. Lett. 2007, 17 (8), 2225–2228. 
(24)  Zhang, P.; Zhang, N.; Korba, B. E.; Hosmane, R. S. Synthesis and in Vitro Anti-
Hepatitis B and C Virus Activities of Ring-Expanded (’fat’) Nucleobase Analogues 
Containing the imidazo[4,5-e][1,3] Diazepine-4,8-Dione Ring System. Bioorganic 
Med. Chem. Lett. 2005, 15 (24), 5397–5401. 
(25)  Bretner, M.; Beckett, D.; Sood, R. K.; Baldisseri, D. M.; Hosmane, R. S. 
Substrate/inhibition Studies of Bacteriophage T7 RNA Polymerase with the 5’-
triphosphate Derivative of a Ring-Expanded (’fat’) Nucleoside Possessing Potent 
Antiviral and Anticancer Activities. Bioorganic Med. Chem. 1999, 7 (12), 2931–2936. 
(26)  Yedavalli, V. S. R. K.; Zhang, N.; Cai, H.; Zhang, P.; Starost, M. F.; Hosmane, R. S.; 
Jeang, K. T. Ring Expanded Nucleoside Analogues Inhibit RNA Helicase and 
Intracellular Human Immunodeficiency Virus Type 1 Replication. J. Med. Chem. 
2008, 51 (16), 5043–5051. 
(27)  Zhang, N.; Chen, H. M.; Koch, V.; Schmitz, H.; Minczuk, M.; Stepien, P.; Fattom, A. 
I.; Naso, R. B.; Kalicharran, K.; Borowski, P.; et al. Potent Inhibition of 
NTPase/Helicase of the West Nile Virus by Ring-Expanded (“Fat”) Nucleoside 
Analogues. J. Med. Chem. 2003, 46 (22), 4776–4789. 
(28)  Zhang, N.; Chen, H. M.; Koch, V.; Schmitz, H.; Liao, C. L.; Bretner, M.; Bhadti, V. 
S.; Fattom, A. I.; Naso, R. B.; Hosmane, R. S.; et al. Ring-Expanded (“fat”) 
Nucleoside and Nucleotide Analogues Exhibit Potent in Vitro Activity against 
Flaviviridae NTPases/helicases, Including Those of the West Nile Virus, Hepatitis C 
Virus, and Japanese Encephalitis Virus. J. Med. Chem. 2003, 46 (19), 4149–4164. 
(29)  Scarborough, C. C.; Popp, B. V.; Guzei, I. A.; Stahl, S. S. Development of 7-
Membered N-Heterocyclic Carbene Ligands for Transition Metals. J. Organomet. 
Chem. 2005, 690 (24–25), 6143–6155. 
(30)  Scarborough, C. C.; Guzei, I. A.; Stahl, S. S. Synthesis and Isolation of a Stable, 
Axially-Chiral Seven-Membered N-Heterocyclic Carbene. Dalton Trans. 2009, No. 
13, 2284–2286. 
(31)  De Borggraeve, W. M.; Van den Bogaert, A. M. 1,3-Diazepines. In Comprehensive 
Heterocyclic Chemistry III; Elsevier, 2008; pp 161–182. 
(32)  Darko, A. K.; Curran, F. C.; Copin, C.; McElwee-White, L. Carbonylation of 
Functionalized Diamine Diols to Cyclic Ureas: Application to Derivatives of DMP 
450. Tetrahedron 2011, 67 (22), 3976–3983. 
(33)  Fesenko, A. A.; Shutalev, A. D. Nucleophile-Mediated Ring Expansion of 4-
Chloromethyl- and 4-Mesyloxymethyl-5-Tosyl-1,2,3,4-Tetrahydropyrimidin-2-Ones to 
6-Tosyl-2,3,4,5-Tetrahydro-1H-1,3-Diazepin-2-Ones: Effect of the Leaving Group and 
the Substituent at C6. Tetrahedron 2011, 67 (36), 6876–6882. 
(34)  Fesenko, A. A.; Shutalev, A. D. 2,3-Dihydro-1H-1,3-Diazepin-2-Ones: Synthesis and 
Novel Rearrangements into Pyrrole Derivatives. Tetrahedron Lett. 2014, 55 (8), 1416–
1420. 
(35)  McCreanor, N. G.; Stanton, S.; Bower, J. F. Capture-Collapse Heterocyclization: 1,3-
Diazepanes by C-N Reductive Elimination from Rhodacyclopentanones. J. Am. Chem. 
Soc. 2016, 138 (36), 11465–11468. 
(36)  Livadiotou, D.; Tsoleridis, C. A.; Stephanidou-Stephanatou, J. A Versatile, 
Unexpected, One-Pot Regioselective Synthesis of a New Class of 1,3-
Diazepinoindolones by Reaction of Pyranoindolones with Monosubstituted Ureas. 
Synthesis 2009, No. 15, 2579–2583. 
(37)  Arama, D. P.; Lisowski, V.; Scarlata, E.; Fulcrand, P.; Maillard, L. T.; Martinez, J.; 
Masurier, N. An Efficient Synthesis of Pyrido-Imidazodiazepinediones. Tetrahedron 
Lett. 2013, 54 (11), 1364–1367. 
(38)  Ozer, M. S.; Koza, G.; Sahin, E.; Balci, M. Furo- and Thieno-Fused 1,3-Diazepine-
4,6-Diones. Tetrahedron Lett. 2013, 54 (48), 6553–6556. 
(39)  Zheng, Y.; Chi, Y.; Bao, M.; Qiu, L.; Xu, X. Gold-Catalyzed Tandem Dual 
Heterocyclization of Enynones with 1,3,5-Triazines: Bicyclic Furan Synthesis and 
Mechanistic Insights. J. Org. Chem. 2017, 82 (4), 2129–2135. 
(40)  Yan, L.; Che, X.; Bai, X.; Pei, Y. Syntheses of Novel diaryl[d,f][1,3]diazepines via 
One-Pot Suzuki Coupling Followed by Direct Ring Closure with Carboxylic Acids. 
Mol. Divers. 2012, 16 (3), 489–501. 
(41)  Tomar, M.; Lucas, N. T.; Müllen, K.; Jacob, J. Facile Synthesis and Coupling of 3,9-
Dibromo-6-Aryl-5H-dibenzo[d,f][1,3] Diazepine Derivatives. Tetrahedron Lett. 2013, 
54 (44), 5883–5885. 
(42)  Kumar, S.; Pratap, R.; Kumar, A.; Kumar, B.; Tandon, V. K.; Ram, V. J. Synthesis of 
Dibenzo[d,f]diazepinones and Alkenylindolinones through Ring Transformation of 
2H-Pyran-2-One-3-Carbonitriles by Indolin-2-Ones. Tetrahedron 2013, 69 (24), 4857–
4865. 
(43)  Wezeman, T.; Hu, Y.; McMurtrie, J.; Bräse, S.; Masters, K. S. Synthesis of Non-
Symmetrical and Atropisomeric Dibenzo[1,3]diazepines: Pd/CPhos-Catalysed Direct 
Arylation of Bis-Aryl Aminals. Aust. J. Chem. 2015, 68 (12), 1859–1865. 
(44)  Cubbage, K. L.; Orr-Ewing, A. J.; Booker-Milburn, K. I. First Higher-Order 
Photocycloaddition to a C=N Bond: 1,3-Diazepines from Maleimides. Angew. Chemie 
- Int. Ed. 2009, 48 (14), 2514–2517. 
(45)  Zaki, M. E. A.; Paula Bettencourt, A.; Fernandes, F. M.; Fernanda Proença, M. 
Synthesis and Electrochemical Evaluation of Substituted imidazo[4,5-d]pyrrolo[3,2-
f][1,3] Diazepine Scaffolds. Tetrahedron 2012, 68 (24), 4628–4634. 
(46)  Masurier, N.; Aruta, R.; Gaumet, V.; Denoyelle, S.; Moreau, E.; Lisowski, V.; 
Martinez, J.; Maillard, L. T. Selective C-Acylation of 2-aminoimidazo[1,2- a 
]Pyridine: Application to the Synthesis of Imidazopyridine-Fused [1,3]diazepinones. J. 
Org. Chem. 2012, 77 (7), 3679–3685. 
(47)  Lebedyeva, I. O.; Povstyanoy, V. M.; Ryabitskii, A. B.; Panasyuk, O.; Ivahnenko, E.; 
Lozova, V. P.; Markevich, I.; Allakhverdova, S.; Povstyanoy, M. V. 
Theophyllinylpyrimidine Scaffolds Undergo Intramolecular Cyclization Reactions to 
Form 1,3-Diazepines and Imidazopurines. Eur. J. Org. Chem. 2013, No. 21, 4594–
4606. 
(48)  Wang, X.; Tang, H.; Feng, H.; Li, Y.; Yang, Y.; Zhou, B. Access to Six- and Seven-
Membered 1,7-Fused Indolines via Rh(III)-Catalyzed Redox-Neutral C7-Selective C-
H Functionalization of Indolines with Alkynes and Alkenes. J. Org. Chem. 2015, 80 
(12), 6238–6249. 
(49)  Gumbau-Brisa, R.; Hayward, J. J.; Wallis, J. D.; Rawson, J. M.; Pilkington, M. 
Structural Insights into the Coordination Chemistry and Reactivity of a 3,3′-Bis-Imine-
2,2′-Bipyridine Ligand. CrystEngComm 2016, 18 (11), 1892–1903. 
(50)  Olkhovik, V. K.; Vasilevskii, D. A.; Pap, A. A.; Kalechyts, G. V.; Matveienko, Y. V.; 
Baran, A. G.; Halinouski, N. A.; Petushok, V. G. Synthesis of New Polyconjugated 
Molecules with Biphenyl, Dibenzothiophene, Carbazole and Phenanthrene Units. 
ARKIVOC (Gainesville, FL, U.S.) 2008, No. 9, 69–93. 
(51)  Hazell, R. G.; Iversen, P. E.; Lehmann, M. S. 5,7-Dihydroxy-6,6-Dimethyl-6,7-
Dihydrodibenzo[ D , F ][1,3]diazepine. Acta Crystallogr. Sect. B Struct. Crystallogr. 
Cryst. Chem. 1978, 34 (11), 3458–3460. 
(52)  Jiang, J.; Chen, X.; Wang, J.; Hui, Y.; Liu, X.; Lin, L.; Feng, X. Chiral Biphenylamide 
Derivative: An Efficient Organocatalyst for the Enantioselective Synthesis of α-
Hydroxy Phosphonates. Org. Biomol. Chem. 2009, 7 (21), 4355–4357. 
(53)  Wisser, F. M.; Eckhardt, K.; Wisser, D.; Böhlmann, W.; Grothe, J.; Brunner, E.; 
Kaskel, S. Tailoring Pore Structure and Properties of Functionalized Porous Polymers 
by Cyclotrimerization. Macromolecules 2014, 47 (13), 4210–4216. 
(54)  Kundu, P. K.; Lerner, A.; Kučanda, K.; Leitus, G.; Klajn, R. Cyclic Kinetics during 
Thermal Equilibration of an Axially Chiral Bis-Spiropyran. J. Am. Chem. Soc. 2014, 
136 (32), 11276–11279. 
(55)  Racané, L.; Čičak, H.; Mihalić, Z.; Karminski-Zamola, G.; Tralić-Kulenović, V. New 
Pentacyclic Ring Systems: Intramolecular Cyclization of O,o′-Disubstituted 
Bibenzothiazoles. Tetrahedron 2011, 67 (15), 2760–2767. 
(56)  Perepichka, I. F.; Kuz’mina, L. G.; Perepichka, D. F.; Bryce, M. R.; Goldenberg, L. 
M.; Popov, A. F.; Howard, J. A. K. Electron Acceptors of the Fluorene Series. 7. 1 2,7-
Dicyano-4,5-Dinitro-9-X-Fluorenes: Synthesis, Cyclic Voltammetry, Charge Transfer 
Complexation with N -Propylcarbazole in Solution, and X-Ray Crystal Structures of 
Two Tetrathiafulvalene Complexes. J. Org. Chem. 1998, 63 (19), 6484–6493. 
(57)  Bjørsvik, H. R.; González, R. R.; Liguori, L. Investigations of a Novel Process to the 
Framework of Benzo[c]cinnoline. J. Org. Chem. 2004, 69 (22), 7720–7727. 
(58)  Sakai, N.; Asama, S.; Anai, S.; Konakahara, T. One-Pot Preparation of Azobenzenes 
from Nitrobenzenes by the Combination of an Indium-Catalyzed Reductive Coupling 
and a Subsequent Oxidation. Tetrahedron 2014, 70 (11), 2027–2033. 
(59)  Elumalai, V.; Bjørsvik, H. R. A Concise Synthesis to Benzo[c]cinnolines via 2,2’-
Dinitro-1,1’-Biphenyls Attained from a Novel Tailored Suzuki Cross-Coupling. 
ChemistrySelect 2017, 2 (29), 9387–9390. 
(60)  Neese, F. The ORCA Program System. Wiley Interdiscip. Rev. Comput. Mol. Sci. 
2012, 2 (1), 73–78. 
(61)  Hehre, W. J.; Ditchfield, K.; Pople, J. A. Self-Consistent Molecular Orbital Methods. 
XII. Further Extensions of Gaussian-Type Basis Sets for Use in Molecular Orbital 
Studies of Organic Molecules. J. Chem. Phys. 1972, 56 (5), 2257–2261. 
(62)  Dill, J. D.; Pople, J. A. Self-Consistent Molecular Orbital Methods. XV. Extended 
Gaussian-Type Basis Sets for Lithium, Beryllium, and Boron. J. Chem. Phys. 1975, 62 
(7), 2921–2923. 
(63)  Francl, M. M.; Pietro, W. J.; Hehre, W. J.; Binkley, J. S.; Gordon, M. S.; DeFrees, D. 
J.; Pople, J. A. Self-Consistent Molecular Orbital Methods. XXIII. A Polarization-
Type Basis Set for Second-Row Elements. J. Chem. Phys. 1982, 77 (7), 3654–3665. 
  
 
